Subscribe to Our Blog. Stay up to date with the latest news and insights.
The popularity of decentralized clinical trials (DCTs) is surging—especially among patients. Harnessing technology of all kinds, these trials provide an attractive alternative to the old-style site-anchored system on which traditional clinical trials have rested. They also have the potential to provide better, more timely data, since that data is largely collected under real-life situations and…
Artificial intelligence technology, including machine learning (ML), is an increasingly hot topic in clinical research, but there are still important questions to be answered when putting these systems into action. This practical webinar will help set your organization up for success by offering a fresh perspective on the key goals of risk-based quality management (RBQM)…
New technologies are inevitably heralded as making life simpler: streamlining tasks, eliminating steps, managing things so you don’t have to manage them. Yet the practical application of a new technology often seems to make things more complex. Clinical trial management is a case in point. Contract Research Organizations (CROs) and sponsors are juggling increased data…
The first QMS that allows you to implement risk-based monitoring (RBM) methodology at scale. In this video, Mike Arlotto, founder of Remarque Systems, discusses how the Remarque Quality Management System can improve trial execution from the patient, site, and study levels with three distinct monitoring modules: Medical Monitor Module: View individual patient details and demographics…
Flexible access to clean, high-quality data and effective risk management are more vital than ever to the success of clinical drug trials. The Remarque Quality Management System is the first that allows sponsors and CROs of all sizes to implement risk-based monitoring (RBM) methodology at scale. In this video, Mike Arlotto, founder of Remarque Systems,…
Flexible access to clean, high-quality data and effective risk management are more vital than ever to the success of clinical drug trials. The Remarque Quality Management System is the first that allows sponsors and CROs of all sizes to implement risk-based monitoring (RBM) methodology at scale. In this video, Mike Arlotto, founder of Remarque Systems,…
Flexible access to clean, high-quality data and effective risk management. The Remarque Quality Management System is the first that allows sponsors and CROs of all sizes to implement risk-based monitoring (RBM) methodology at scale. In this video, Mike Arlotto, founder of Remarque Systems, discusses how the platform can improve trial execution from the patient level.…
The term “risk-based monitoring” (or RBM) has been widely used throughout the pharmaceutical industry, but what it really means and how it is implemented is the source of much debate. In this webcast, we’ll address five common myths of RBM and show how a quality management-based approach can set your clinical trial up for success:…